|
Chlorine in PDB 8hje: Vismodegib Binds to the Catalytical Domain of Human Ubiquitin-Specific Protease 28Enzymatic activity of Vismodegib Binds to the Catalytical Domain of Human Ubiquitin-Specific Protease 28
All present enzymatic activity of Vismodegib Binds to the Catalytical Domain of Human Ubiquitin-Specific Protease 28:
3.4.19.12; Protein crystallography data
The structure of Vismodegib Binds to the Catalytical Domain of Human Ubiquitin-Specific Protease 28, PDB code: 8hje
was solved by
L.Shi,
H.Wang,
Z.Xu,
B.Xiong,
N.Zhang,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Vismodegib Binds to the Catalytical Domain of Human Ubiquitin-Specific Protease 28
(pdb code 8hje). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Vismodegib Binds to the Catalytical Domain of Human Ubiquitin-Specific Protease 28, PDB code: 8hje: Jump to Chlorine binding site number: 1; 2; Chlorine binding site 1 out of 2 in 8hjeGo back to![]() ![]()
Chlorine binding site 1 out
of 2 in the Vismodegib Binds to the Catalytical Domain of Human Ubiquitin-Specific Protease 28
![]() Mono view ![]() Stereo pair view
Chlorine binding site 2 out of 2 in 8hjeGo back to![]() ![]()
Chlorine binding site 2 out
of 2 in the Vismodegib Binds to the Catalytical Domain of Human Ubiquitin-Specific Protease 28
![]() Mono view ![]() Stereo pair view
Reference:
D.Zhou,
Z.Xu,
Y.Huang,
H.Wang,
X.Zhu,
W.Zhang,
W.Song,
T.Gao,
T.Liu,
M.Wang,
L.Shi,
N.Zhang,
B.Xiong.
Structure-Based Discovery of Potent USP28 Inhibitors Derived From Vismodegib. Eur.J.Med.Chem. V. 254 15369 2023.
Page generated: Tue Jul 30 10:21:01 2024
ISSN: ISSN 0223-5234 PubMed: 37075624 DOI: 10.1016/J.EJMECH.2023.115369 |
Last articlesZn in 9MJ5Zn in 9HNW Zn in 9G0L Zn in 9FNE Zn in 9DZN Zn in 9E0I Zn in 9D32 Zn in 9DAK Zn in 8ZXC Zn in 8ZUF |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |